Cellosaurus logo
expasy logo

Cellosaurus P3XBcl-2-13 (CVCL_B6NI)

[Text version]
Cell line name P3XBcl-2-13
Accession CVCL_B6NI
Resource Identification Initiative To cite this cell line use: P3XBcl-2-13 (RRID:CVCL_B6NI)
Comments Group: Hybridoma fusion partner cell line.
Characteristics: Enhances the outgrowth of hybridomas following somatic fusion with immune lymphocytes isolated from pooled peripheral lymph nodes (PLN) 8-14 days after the initial immunization (PubMed=9309429).
Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
Transfected with: HGNC; 990; BCL2.
Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
Disease Mouse plasma cell myeloma (NCIt: C125417)
Species of origin Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Breed/subspecies: BALB/c.
Hierarchy Parent: CVCL_4032 (P3X63Ag8.653)
Children:
CVCL_B6NM (Eph099B-102.147)CVCL_B6NN (Eph099B-208.261)CVCL_B6NP (Eph099B-210.248)
CVCL_B6NQ (Eph099B-233.152)CVCL_B6NJ (Flt-3A20.9)CVCL_B6NK (Flt-3B3.33)
CVCL_B6NL (Flt-3B7.5)
Sex of cell Female
Category Cancer cell line
Publications

PubMed=9309429; DOI=10.1089/hyb.1997.16.381
Kilpatrick K.E., Wring S.A., Walker D.H., Macklin M.D., Payne J.A., Su J.-L., Champion B.R., Caterson B., McIntyre G.D.
Rapid development of affinity matured monoclonal antibodies using RIMMS.
Hybridoma 16:381-389(1997)

Cross-references
Encyclopedic resources Wikidata; Q112129483
Entry history
Entry creation17-Mar-2022
Last entry update21-Mar-2023
Version number3